tolvaptan has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamo, V; Campo, S; Lacquaniti, A; Monardo, P; Russo, A | 1 |
| Grassi, P; Peverelli, G | 1 |
2 other study(ies) available for tolvaptan and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tolvaptan | 2023 |
Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brachytherapy; Carcinoma, Small Cell; Humans; Inappropriate ADH Syndrome; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Syndrome; Tolvaptan | 2017 |